← Leaderboards
Jeffrey D Hasday
Baltimore Va Medical Center
$7,284,092
Attributed
$8,085,469
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $839.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,085,469 · 5
VA$0 · 2
By mechanism
R01$8,085,469 · 5
I01$0 · 2
Top collaborators
- Paul S Shapiro5 shared
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionIn VivoIn VitroLungInjuryLung InjuryFeverInflammationPathway InteractionsPhosphotransferasesMouse ModelLeadMolecularSignal PathwayHyperthermiaCellsNeutrophilExposure ToComplicationInduced HyperthermiaMitogen-Activated Protein KinasesEpithelialMapk14 GeneBody Temperature
Grant awards (36)
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome$0
I01 · FY2025 · VA · contact PI
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome$0
I01 · FY2024 · VA · contact PI
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome$0
I01 · FY2023 · VA · contact PI
Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome$0
I01 · FY2022 · VA · contact PI
Design of Novel Non-catalytic Substrate-Selective p38 MAPK Inhibitor to Treat ARDS$0
I01 · FY2020 · VA · contact PI
Design of Novel Non-catalytic Substrate-Selective p38 MAPK Inhibitor to Treat ARDS$0
I01 · FY2019 · VA · contact PI
Design of Novel Non-catalytic Substrate-Selective p38 MAPK Inhibitor to Treat ARDS$0
I01 · FY2018 · VA · contact PI
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury$383,750
R01 · FY2016 · HL · contact PI
Hyperthermia-augmented epithelial apoptosis and acute lung injury$0
I01 · FY2016 · VA · contact PI
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury$377,993
R01 · FY2015 · HL · contact PI
Hyperthermia-augmented epithelial apoptosis and acute lung injury$0
I01 · FY2015 · VA · contact PI
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury$376,075
R01 · FY2014 · HL · contact PI
Novel Mechanisms of Smooth Muscle Beta2-receptor Regulation Relevant to Asthma$363,825
R01 · FY2014 · HL · contact PI
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury$99,606
R01 · FY2014 · HL · contact PI
Hyperthermia-augmented epithelial apoptosis and acute lung injury$0
I01 · FY2014 · VA · contact PI
p38MAP kinase-dependent mechanisms of fever-enhanced acute lung injury$365,330
R01 · FY2013 · HL · contact PI
Hyperthermia-augmented epithelial apoptosis and acute lung injury$0
I01 · FY2013 · VA · contact PI
Mechanisms of Fever-Enhanced Acute Lung Injury$375,000
R01 · FY2011 · HL · contact PI
Mechanisms of Fever-Enhanced Acute Lung Injury$375,000
R01 · FY2010 · HL · contact PI
The contribution of heat shock/stress pathways to acute lung injury$334,125
R01 · FY2010 · HL · contact PI
Mechanisms of Fever-Enhanced Acute Lung Injury$375,000
R01 · FY2009 · HL · contact PI
The contribution of heat shock/stress pathways to acute lung injury$334,125
R01 · FY2009 · HL · contact PI
Mechanisms of Fever-Enhanced Acute Lung Injury$375,000
R01 · FY2008 · HL · contact PI
The contribution of heat shock/stress pathways to acute lung injury$334,125
R01 · FY2008 · HL · contact PI
The contribution of heat shock/stress pathways to acute lung injury$362,278
R01 · FY2007 · HL · contact PI
Mechanisms of HSF1-mediated Repression of TNF-alpha$305,721
R01 · FY2007 · GM · contact PI
Mechanisms of HSF1-mediated Repression of TNF-alpha$376,139
R01 · FY2006 · GM · contact PI
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury$362,526
R01 · FY2006 · HL · contact PI
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury$371,250
R01 · FY2005 · HL
Mechanisms of HSF1-mediated Repression of TNF-alpha$303,515
R01 · FY2005 · GM
Mechanisms of HSF1-mediated Repression of TNF-alpha$62,370
R01 · FY2005 · GM
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury$371,250
R01 · FY2004 · HL
Mechanisms of HSF1-mediated Repression of TNF-alpha$311,850
R01 · FY2004 · GM
Mechanisms of Fever-Enhanced Hyperoxic Lung Injury$371,250
R01 · FY2003 · HL
BODY TEMPERATURE AND REGULATING HOST DEFENSES$204,743
R01 · FY2001 · AI
BODY TEMPERATURE AND REGULATING HOST DEFENSES$213,623
R01 · FY2000 · AI